Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

News > France & Monaco

Please find below news from France and Monaco as well as about organisations from these countries.

Total search results: 1485 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Poxel S.A.. (4/30/15). "Press Release: 2014 Annual Results in Line with a Major Post-Closing Event – the Successful Company IPO in February 2015". Lyon. 2015-04-30
AB Science S.A.. (4/30/15). "Press Release: 2014 Revenues of 2,099 K€. Clinical Trial with Masitinib in 13 Phase 3 Studies". Paris. 2015-04-30
OSE Pharma S.A.. (4/29/15). "Press Release: 2014 Key Steps and 2015 Outlook. 2014 Annual Results [Not for distribution directly or indirectly in the United States, Canada, Australia or Japan]". Paris. 2015-04-29
TxCell S.A.. (4/28/15). "Press Release: TxCell Appoints Stéphane Boissel as Chief Executive Officer and Promotes Miguel Forte to Chief Operating Officer". Valbonne. 2015-04-28
PEP-Therapy. (4/27/15). "Press Release: PEP-Therapy Raises €1.3 Million in Seed Capital. The Company Is Undertaking Development of Its First Drug Candidate and Its Companion Diagnostic in Oncology". Paris. 2015-04-27
Hybrigenics S.A.. (4/27/15). "Press Release: Hybrigenics Full Year 2014 Results. Strong Cash Position further Recently Increased by EUR 9 million". Paris. 2015-04-27
MedDay Pharmaceuticals S.A.S.. (4/24/15). "Press Release: MedDay Announces Its Pivotal Phase III Study of MD1003 in Patients with Progressive Multiple Sclerosis Meets Primary Endpoint". Paris. 2015-04-24
TxCell S.A.. (4/23/15). "Press Release: TxCell and Trizell Amend Collaboration Agreement to Accelerate Ovasave Development". Valbonne. 2015-04-23
Novasep S.A.. (4/21/15). "Press Release: Novasep Reports Strong 2014 Full Year Results. Swift Execution of »Back to Basics« Strategic Plan Leading to Successful Portfolio Reshaping". Lyon Gerland. 2015-04-21
MedDay Pharmaceuticals S.A.S.. (4/17/15). "Press Release: MedDay Reports Positive Pivotal Phase III Study Results with MD1003 in Patients with Progressive Multiple Sclerosis". Paris. 2015-04-17
Genticel S.A.. (4/9/15). "Press Release: Genticel Strengthens Management Team and Appoints Valerie Leroy as Senior Director, Corporate Communications and Investor Relations". Paris & Toulouse. 2015-04-09
Cellectis S.A.. (4/8/15). "Press Release: Cellectis Opens Labs and Offices in Manhattan, New York". New York, NY. 2015-04-08
Ipsen S.A.. (4/8/15). "Press Release: Ipsen and Hannover Medical School Start Joint Research in Recombinant Botulinum Neurotoxins for Targeted Secretion Inhibitors. Key Steps in Thirty Months Research Program Underway". Paris & Hannover. 2015-04-08
ImaBiotech S.A.S.. (4/6/15). "Press Release: Iteos and ImaBiotech Awarded Grant for Tumor Microenvironment Characterization and Applications in Immuno-oncology". Gosselies & Loos. 2015-04-06
Diaxonhit S.A.. (3/26/15). "Press Release: Group 2014 Annual Results. Further Improvement of Operating Result and Significant Progress in Line with the Strategic Plan". Paris. 2015-03-26
Valneva S.E.. (3/26/15). "Press Release: Valneva Announces Approval of an EB66-based Prototype Influenza Vaccine in Japan". Lyon. 2015-03-26
OSE Pharma S.A.. (3/25/15). "Press Release: Ose Pharma Completes a Highly Successful IPO on Euronext Paris and Raises 21,1 M€ [Not for distribution directly or indirectly in the United States, Canada, Australia or Japan]". Paris. 2015-03-25
Cerenis Therapeutics S.A.. (3/25/15). "Press Release: Outstanding Success of Cerenis Therapeutics’ IPO with €53.4 Million Raised on Euronext Paris [Not for United States, Canada, Australia or Japan]". Toulouse & Ann Arbor, MI. 2015-03-25
Cellectis S.A.. (3/24/15). "Press Release: Cellectis Prices Initial Public Offering of American Depositary Shares". Paris. 2015-03-24
HalioDx S.A.S.. (3/23/15). "Press Release: Creation of HalioDx. A Management Buy-out by the Qiagen Marseille Executive Team". Marseille. 2015-03-23
Evotec AG. (3/20/15). "Press Release: Evotec and Sanofi Sign Definitive Agreement for Major Multi-component Strategic Alliance. Total Deal Value of EUR 250 m, including more than EUR 40 m Upfront Cash Payment". Hamburg. 2015-03-20
Advanced Chemistry Development, Inc. (ACD/Labs). (3/18/15). "Press Release: Better Academic Chemistry Knowledge Sharing. Building an Analytical Knowledge Management System at the Faculty of Pharmacy of the University of Strasbourg". Strasbourg. 2015-03-18
bioMérieux S.A.. (3/11/15). "Press Release: 2014 Financial Results". Marcy l’Étoile. 2015-03-11
Sygnis AG. (3/10/15). "Press Release: Sygnis Signs Non-exclusive Distribution Agreement for TruePrime Product Family with Ozyme France". Madrid & Heidelberg. 2015-03-10
Nicox S.A.. (3/6/15). "Press Release: Nicox Announces Financing of €27 Million to Support Its Growth Strategy [Not for United States of America, Canada, Japan or Australia]". Sophia Antipolis. 2015-03-06
Cellectis S.A.. (3/4/15). "Press Release: 2014 Financial Results". Paris. 2015-03-04
AB Science S.A.. (2/27/15). "Press Release: Quarterly Information – Fourth quarter 2014. Turnover up 10% Compared to 2013 Fourth Quarter". Paris. 2015-02-27
Ipsen S.A.. (2/24/15). "Press Release: Ipsen Enters into Option Agreement to Acquire Canbex Therapeutics". Paris & London. 2015-02-24
Carbios S.A.. (11/2/15). "Press Release: Carbios Receives € 1.6 Million from Bpifrance for Completing the Third Development Stage of the Thanaplast Project". Clermont-Ferrand. 2015-02-11
Inoviem Scientific. (2/10/15). "Press Release: Inoviem Scientific Raises €500,000 ($566,000) in Seed Funding from Cap Innov’Est". Strasbourg. 2015-02-10
Poxel S.A.. (2/5/15). "Press Release: Success of the IPO of Poxel. Almost Full Exercise of the Extension Option – €25.0m Raised on Euronext in Paris – Offer Price Set at €6.66 per Share [not for US, CA, AU, JP or to U.S.persons]". Lyon. 2015-02-05
Valneva S.E.. (2/4/15). "Press Release: Valneva Announces the Successful Completion of Its EUR 45 Million Capital Increase [Not for United States, Canada, Australia or Japan]". Lyon. 2015-02-04
PPF Group N.V.. (2/4/15). "Press Release: PPF Group Acquires a Minority Stake in Biotech Company Cytune Pharma in Cooperation with Sotio". 2015-02-04
Magnisense SE. (2/2/15). "Press Release: Magnisense Receives €1.2 Million in Financing from Bpifrance for Its Innovative MI² Project to Develop Emergency Diagnostic Tests for Cardiovascular Diseases". Paris. 2015-02-02
Genticel S.A.. (2/2/15). "Press Release: Genticel Licenses Vaxiclase Platform to Serum Institute of India for Use in Pertussis Vaccines". Paris & Toulouse. 2015-02-02
Valneva S.E.. (1/29/15). "Press Release: Valneva Grants Exclusive Worldwide License to Immune Targeting Systems for the Development of Hepatitis B Vaccines in Combination with the IC31 Adjuvant". Lyon. 2015-01-29
Bionext. (1/28/15). "Press Release: Bionext Raises €1M in Seed Funding from the Cap Innov'Est Fund and Angel investors". Strasbourg. 2015-01-28
Sartorius AG. (1/27/15). "Press Release: Preliminary Results 2014. Sartorius Stedim Biotech with Strong Growth Across the Entire Product Portfolio and All Regions – Positive Outlook for 2015". 2015-01-27
JEOL Ltd.. (1/27/15). "Press Release: JEOL (Europe) SAS Donates NMR to BIPM". 2015-01-27
bioMérieux S.A.. (1/22/15). "Press Release: bioMérieux and Astute Medical Sign a Global Agreement to Develop and Market NephroCheck Test for VIDAS, an Assay to Assess the Risk of Developing Acute Kidney Injury". Marcy l’Étoile & San Diego, CA. 2015-01-22
bioMérieux S.A.. (1/22/15). "Press Release: Business Review for the Three Months and Full Year Ended December 31, 2014". Marcy l’Étoile. 2015-01-22
Carbios S.A.. (1/20/15). "Press Release: Carbios Appoints Raquel Lizarraga as Head of Investor Relations". Clermont-Ferrand. 2015-01-20
Seventure Partners. (1/20/14). "Press Release: Seventure Partners Launches New €120m »Health For Life Capital« Innovation Fund Dedicated to Life Sciences". Paris. 2015-01-20
MedDay Pharmaceuticals S.A.S.. (1/14/15). "Press Release: MedDay Provides Update on Pipeline Progress". Paris. 2015-01-14
Diaxonhit S.A.. (1/14/15). "Press Release: Diaxonhit Announces the CE Marking of the BJI InoPlex Test and Its Commercial Launch". Paris. 2015-01-14
MedDay Pharmaceuticals S.A.S.. (1/13/15). "Press Release: MedDay Appoints Philippe Goupit to Its Board of Directors". Paris. 2015-01-13
Cellectis S.A.. (1/13/15). "Press Release: Cellectis and Ohio State University, through the Ohio State Innovation Foundation, Enter into Licensing Agreement for Chimeric Antigen Receptor Technology Targeting Multiple Myeloma". Paris. 2015-01-13
Diaxonhit S.A.. (1/12/15). "Press Release: Diaxonhit Announces that Strasbourg University Hospital Will Become its European Central Laboratory for Processing the CareDx AlloMap Heart Transplant Tests". Paris. 2015-01-12
bioMérieux S.A.. (1/9/15). "Press Release: Strategic Alliance between bioMérieux and Copan to Automate Clinical Microbiology Laboratories and Enhance Their Operational Efficiency". Marcy l’Étoile & Brescia. 2015-01-09
Oddo & Cie. (1/7/15). "Press Release: The Completion of the Acquisition of Seydler, Mittelstand Specialist, Transforms the Oddo Group into a Franco-German Player". Paris. 2015-01-07
Cellectis S.A.. (1/6/15). "Press Release: Cellectis Announces the Issuance by the USPTO of a Patent Covering a Seminal Nuclease-based “Gene Editing” Method". Paris. 2015-01-06
Adocia S.A.. (12/19/14). "Press Release: Lilly and Adocia Announce Alliance to Co-develop Ultra-rapid Insulin Based on BioChaperone Technology". Lyon & Indianapolis, IN. 2014-12-19
France Biotech. (12/18/14). "Press Release: France Biotech Presents the Results of Its Twelfth Annual Survey, »Panorama of the Life Sciences«". Paris. 2014-12-18
Ynsect S.A.. (12/17/14). "Press Release: Ynsect Raised 5.5 Million Euros During Its Second Funding Campaign". 2014-12-17
Neovacs S.A.. (12/16/14). "Press Release: Neovacs Announces Top Line Phase IIb Clinical Trial Results of TNF-Kinoid in Rheumatoid Arthritis and Update on Clinical Programs". Paris. 2014-12-16
Carlina Technologies. (12/16/14). "Press Release: Carlina Technologies Signs a Partnership Agreement with Atlangram to Develop Controlled-release Forms of Antibiotics Targeting Osteoarticular Diseases". Angers. 2014-12-16
IntegraGen S.A.. (12/16/14). "Press Release: IntegraGen Collaborating with PICCOLO Study Investigators to Validate Hsa-miR-31-3p Metastatic Colorectal Cancer Biomarker". Evry. 2014-12-16
Curie-Cancer. (12/16/14). "Press Release: Curie-Cancer and GamaMabs Pharma Renew Their Research Partnership to Develop an Antibody for Gynecological Cancers". Paris & Toulouse. 2014-12-16
Biovision (Fondation pour l’Universite de Lyon / Andrew Lloyd & Associates). (12/15/14). "Press Release: Funding Tomorrow’s Life Science Innovators. The 2015 Investor Conference at Biovision". 2014-12-15
Novacyt S.A.. (12/15/14). "Press Release: Transition to Continous Trading". Paris & Cambridge. 2014-12-15
Valneva S.E.. (12/11/14). "Press Release: Valneva and BliNK Therapeutics Announce Launch of New Biotech Company in Innovative Antibody Discovery. New company Has Already Secured First Round of Financing". Louvain-la-Neuve. 2014-12-11
Alizé Pharma S.A.S.. (12/10/14). "Press Release: Alizé Pharma Announces Positive Results for AZP-531, Its Unacylated Ghrelin Analog, from Two Phase I Clinical Trials in Healthy Volunteers and Obese Subjects". Lyon. 2014-12-10
Valneva S.E.. (12/10/14). "Press Release: Valneva Announces Publication of First Phase II Data of Tuberculosis Vaccine Candidate Formulated with IC31® Adjuvant. Clinical Trial in HIV-infected Adults Showed Good Safety and Immunogenicity". Lyon. 2014-12-10
Roche. (12/10/14). "Press Release: Roche’s Preeclampsia Test Helps to Predict this Life-threatening Condition in Pregnant Women at Risk. New Data Demonstrate High Prognostic Value of Elecsys Blood Test". Basel. 2014-12-10
Novacyt S.A.. (12/8/14). "Press Release: Novacyt Announces a €3.1m Capital Raise and Prepares for New Market Launches". Paris & Cambridge. 2014-12-08
Alizé Pharma S.A.S.. (12/3/14). "Press Release: Alizé Pharma Acquires Exclusive Worldwide Rights on a New Peptide to Tackle Bone Diseases". Lyon. 2014-12-03
Evotec AG. (12/2/14). "Press Release: Evotec and Sanofi Enter Into Exclusive Negotiations for a Major Multi-component Strategic Collaboration. Expect to Sign the Transaction in H1 2015". Hamburg. 2014-12-02
Sanofi S.A.. (12/2/14). "Press Release: Sanofi Receives FDA Approval of Priftin (rifapentine) Tablets for the Treatment of Latent Tuberculosis Infection". Paris. 2014-12-02
IntegraGen S.A.. (12/2/14). "Press Release: IntegraGen Obtains Exclusive Worldwide License for Two Molecular Signatures for Patients with Liver Cancer". Evry. 2014-12-02
Vaxon Biotech S.A.. (12/1/14). "Press Release: Vaxon Biotech Randomizes the 110th Patient in Its Oncology Vaccine Phase IIB Clinical Study in NSCLC. Oncology Vaccine Vx-001 Is the Only One in the World to Use Optimized Cryptic Peptides". Paris. 2014-12-01
Accovion GmbH. (12/1/14). "Press Release: Accovion Launches New Subsidiary in France". Frankfurt & Eschborn. 2014-12-01
GamaMabs Pharma S.A.. (11/27/14). "Press Release: GamaMabs Pharma Signs a Collaboration Agreement with Mayo Clinic". Toulouse. 2014-11-27
Neovacs S.A.. (11/24/14). "Press Release: Neovacs Granted 1 Million Europe in Research Tax Credit". Paris. 2014-11-24
Stallergenes S.A.. (11/20/14). "Press Release: Stallergenes and ActoGenix to Develop an Innovative New Class of Oral Allergy Treatments". Antony & Ghent. 2014-11-20
bioMérieux S.A.. (11/18/14). "Press Release: bioMérieux and Illumina Enter Agreement to Co-Develop a Next-generation Sequencing Solution for Epidemiological Monitoring of Bacterial Infections". Marcy l’Étoile & San Diego, CA. 2014-11-18
Sofimac Partners. (11/17/14). "Communiqué de Presse: Theranexus Lève avec Succès 3,6 M€ en Amorçage". 2014-11-17
Novasep S.A.. (11/13/14). "Press Release: Novasep and Partner Nilsan Nishotech to Install the First Continuous Chromatography System at Laurus Labs". Pompey. 2014-11-13
Enterome Bioscience S.A.. (11/12/14). "Press Release: Enterome Enters into a Microbiome-based Development Collaboration with AbbVie in Crohn’s Disease". Paris. 2014-11-12
Servier. (11/12/14). "Press Release: Intarcia and Servier Sign Ex-U.S. Partnership for ITCA 650 in Diabetes, Intarcia Retains Independence and Full Control of the U.S. and Japan". Boston, MA. 2014-11-12
Diaxonhit S.A.. (11/12/14). "Press Release: Renewal of Commercial Partnership with One Lambda, Inc. for Diagnostic Tests in Transplantation". Paris. 2014-11-12
Cellectis S.A.. (11/12/14). "Press Release: Cellectis Received Proceeds of €13 Million through the Exercise of Warrants". Paris. 2014-11-12
Valneva S.E.. (11/6/14). "Press Release: Valneva Announces Best Quarterly Results Since Vivalis/Intercell Merger, Meets Business Objectives amd Reconfirms Full Year Outlook". Lyon. 2014-11-06
Carlina Technologies. (11/4/14). "Press Release: Carlina Technologies Signs a Partnership Agreement with Genbiotech to Develop a Sustained-release Protein Formulation for Cartilage Repair". Angers. 2014-11-04
Abivax S.A.. (10/30/14). "Press Release: Abivax Strengthens Executive Management Team with Senior Appointments Karl Birthistle, M.D., Appointed VP of Global Regulatory Affairs Daniel Kenny Appointed Chief Commercial Officer & VP of Business Development". 2014-10-30
Novacyt S.A.. (10/30/14). "Press Release: Novacyt Announces 2014 Half Year Results and Updates Strong Progress with Integration of Lab21". Paris & Cambridge. 2014-10-30
Polyplus-transfection S.A.. (10/28/14). "Press Release: Polyplus-transfection and Blue Sky BioServices Sign a Research and Commercial License Agreement for Use of PEI-based Transfection Technologies". Strasbourg. 2014-10-28
bioMérieux S.A.. (10/22/14). "Press Release: Business Review for the Nine Months Ended September 30, 2014". Marcy l’Étoile. 2014-10-22
Transgene S.A.. (10/21/14). "Press Release: Transgene Announces Third Quarter 2014 Financial Results". Strasbourg. 2014-10-21
bioMérieux S.A.. (10/10/14). "Press Release: bioMérieux Inaugurates a New Multidisciplinary R&D Center for Infectious Disease Diagnostics". Marcy l’Étoile. 2014-10-10
Novasep S.A.. (10/2/14). "Press Release: Novasep to Sell Its Bahamian Plant to Local Investor". Pompey. 2014-10-02
VitamFero S.A.. (9/30/14). "Press Release: VitamFero Successfully Secures Its Third Round of Financing". 2014-09-30
Bionomics Ltd.. (9/23/14). "Press Release: Bionomics Acquires Prestwick Chemical. Pre-existing Business Integration and Strong Synergies". 2014-09-23
Vexim S.A.. (9/22/14). "Press Release: Vexim Announces Strong 2014 Half-year Results". Toulouse. 2014-09-22
bioMérieux S.A.. (9/18/14). "Press Release: bioMérieux Launches chromID Salmonella Elite, the New Generation of Culture Media for Earlier Detection of Salmonella Strains in Clinical Fecal Smaples". Marcy l’Étoile. 2014-09-18
Innate Pharma S.A.. (9/17/14). "Press Release: First Half of 2014 – Broadened Clinical Portfolio and Strengthened Cash Position". 2014-09-17
Novacyt S.A.. (9/17/14). "Press Release: Novacyt Appoints Anthony Dyer as Finance Director". Paris & Cambridge. 2014-09-17
Alizé Pharma S.A.S.. (9/10/14). "Press Release: Alizé Pharma Raises EUR 5 Million (USD 6.6 Million) from Bpifrance/InnoBio and Its Existing Shareholders". Lyon. 2014-09-10
Poxel S.A.. (9/9/14). "Press Release: Poxel Raises EUR10 Million from New Investors to Progress Clinical Development of Two Novel Type 2 Diabetes Therapies". Lyon. 2014-09-09
Vexim S.A.. (9/8/14). "Press Release: Vexim Opens U.S. Subsidiary. Office to Support Vexim’s Product Portfolio Launch in the U.S.". Toulouse. 2014-09-08
Cellectis S.A.. (9/4/14). "Press Release: Cellectis Announces the Closing of the Sale of Its Swedish Subsidiary Cellectis AB to Takara Bio Inc.". Paris. 2014-09-04
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15  next pagenext page



Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Partnering Opens 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top